ACC 2022 Conference Coverage
P

ACC 2022: An Embarrassment of Riches - Updated Guideline Recommendations for HFrEF and HFmrEF Treatment

By ACC 2022 Conference Coverage FEATURING Paul Heidenreich
April 21, 2022
5 Comments
Login to view comments. Click here to Login

Featured Video

08:56
Novo Nordisk – GLP-1 RA Therapy

Reaching A1C Goals With GLP-1 RA Injectables: What Does This Trial D…

Feat. R. Pratley

Featured Video

23:07
Novo Nordisk – GLP-1 RA Therapy

Examining Clinical Trial Data on GLP-1 RAs and Basal Insulin in T2D:…

Feat. L. Coco, J. R. Gavin III

Related Content

AUTOPLAY
[REMOVED] ConvaTec
Risk Mitigation of Infection and Post-Operative Wound Complications …
Tue, Jul 28, 2020
Faculty: ConvaTec , Theofanie Mela , Bruce Wilkoff , Peter Belott , Charles Love
Boston Scientific
S-ICD as a first-line therapy: Results from the PRAETORIAN & UNTOUCH…
Thu, Nov 5, 2020
Faculty: Michael Gold , Reinoud Knops , Boston Scientific , Ulrika Birgersdotter-Green
Boston Scientific
Integrated Heart Failure Patient Management — EP and HF Perspective
Wed, Sep 22, 2021
Faculty: Boston Scientific , Camille Frazier-Mills , Marat Fudim , Adrian Hernandez
64:45
Symposium on Diabetes and Cancer 2017: Novel Links and Treatments

Primer on Diabetes Management

Feat. S. Inzucchi
13:06
Boston Scientific

S-ICD Case Observation

Feat. C. Gottlieb
11:25
ACC 2023 Conference Coverage

ACC 2023: SGLT2i Use - Dos and Don'ts

Feat. A. Armbruster
18:43
ASPC 2019 Congress on CVD Prevention

Diabetes Treatment Guidelines Finally Have Entered the 21st Century …

Feat. R. DeFronzo
26:01
Cardiology Fiesta 2017

Renal, Metabolic and Cardiovascular Considerations of SGLT2 Inhibiti…

Feat. R. DeFronzo
17:44
Rita Jermyn

SGLT2 Inhibitors: For Heart Failure, Diabetes, and Renal Disease

27:24
Cardiometabolic Health Congress (CMHC)

SGLT2 Inhibitors, GLP1 Receptor Agonists, and Renal Outcomes

Feat. L. Sloan
13:07
Michelle Kittleson

2021 ADA Highlights: Heart Failure With Reduced Ejection Fraction - …

09:52
AHA 2022 Conference Coverage

AHA 2022: Torsemide Comparison With Furosemide for Management of Hea…

Feat. R. Mentz
57
Boston Scientific

Tailor LUX-Dx ICM Program Settings Remotely

Feat. D. Perschbacher
04:48
Boston Scientific

Engineered for Advance Control

Feat. D. Perschbacher, S. Vanderline, J. Kelly, S. Saha
02:44
Boston Scientific

LUX-Dx ICM Tachycardia Algorithm

01:02
Boston Scientific

How the LUX-Dx ICM Morphology Assessment Works

Feat. D. Perschbacher
14:18
CCM® Therapy

The CCM Solution: How Does it Work and What Does it Do?

Feat. N. Varma
09:19
CCM® Therapy

From Referral to Implant: The Real-World Experience of a High-Volume…

Feat. J. Kuschyk
30:07
MUSC Cardiology

Hypertrophic Cardiomyopathy as a Form of HFpEF: Diagnosis, Drugs and…

Feat. J. Atkins
18:00
ACC 2023 Conference Coverage

ACC 2023: Catch Them Before They Fall - Syncope Guidelines in Action

Feat. B. Olshansky
19:30
ACC 2022 Conference Coverage

Hot Topics in Heart Failure ACC.22

Feat. N. Ibrahim
22:48
Scripps Health

Heart Failure with Preserved Ejection Fraction: New Treatments

Feat. R. C. Mohan
18:05
The Texas Heart Institute

Inside the Studio w/ Dr. Stephanie Coulter | Dr. Darren McGuire

Feat. S. Coulter, D. K. Mcguire